Stockscreener 앱 받기
51.19
0.36%
0.12
전일 마감가:
$51.07
열려 있는:
$51
하루 거래량:
106.40K
Relative Volume:
0.07
시가총액:
$7.03B
수익:
$550.17M
순이익/손실:
$201.35M
주가수익비율:
51.19
EPS:
1
순현금흐름:
$232.07M
1주 성능:
+6.78%
1개월 성능:
-23.32%
6개월 성능:
+0.46%
1년 성능:
-4.27%
1일 변동 폭
$50.88
$51.64
1주일 범위
$46.04
$51.64
52주 변동 폭
$46.04
$85.21
Doximity Inc Stock (DOCS) Company Profile
명칭
Doximity Inc
전화
(650) 549-4330
주소
500 THIRD STREET, SUITE 510, SAN FRANCISCO
DOCS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
51.20 | 9.62B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
242.81 | 39.44B | 3.08B | 860.33M | 1.33B | 5.1481 |
|
TEM
Tempus Ai Inc
|
78.06 | 13.67B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
105.10 | 9.08B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.24 | 7.07B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-21 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | 개시 | BMO Capital Markets | Market Perform |
| 2025-10-27 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-10-10 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-10-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-07-09 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-06-02 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-02-07 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-11-15 | 개시 | Goldman | Neutral |
| 2024-11-14 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-09 | 업그레이드 | Needham | Hold → Buy |
| 2024-07-18 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2024-01-02 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-08-09 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-08-09 | 다운그레이드 | Needham | Buy → Hold |
| 2023-08-03 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | 개시 | Wells Fargo | Overweight |
| 2022-10-24 | 개시 | Evercore ISI | In-line |
| 2022-10-13 | 개시 | BTIG Research | Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-28 | 개시 | Berenberg | Buy |
| 2022-05-18 | 재확인 | BofA Securities | Neutral |
| 2022-05-18 | 재확인 | Goldman | Buy |
| 2022-05-18 | 재확인 | Guggenheim | Buy |
| 2022-05-18 | 재확인 | Jefferies | Buy |
| 2022-05-18 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 재확인 | Needham | Buy |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-04 | 개시 | BofA Securities | Neutral |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2021-12-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-11-17 | 개시 | Robert W. Baird | Outperform |
| 2021-11-10 | 재확인 | Canaccord Genuity | Buy |
| 2021-11-10 | 재확인 | Goldman | Neutral |
| 2021-11-10 | 재확인 | Morgan Stanley | Equal-Weight |
| 2021-11-10 | 재확인 | Needham | Buy |
| 2021-11-10 | 재확인 | Piper Sandler | Overweight |
| 2021-08-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-19 | 개시 | Canaccord Genuity | Buy |
| 2021-07-19 | 개시 | Goldman | Neutral |
| 2021-07-19 | 개시 | JP Morgan | Overweight |
| 2021-07-19 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-07-19 | 개시 | Piper Sandler | Overweight |
| 2021-07-19 | 개시 | Raymond James | Outperform |
| 2021-07-19 | 개시 | SVB Leerink | Outperform |
| 2021-07-19 | 개시 | William Blair | Outperform |
모두보기
Doximity Inc 주식(DOCS)의 최신 뉴스
SG Americas Securities LLC Lowers Stake in Doximity, Inc. $DOCS - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Trims Position in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. $DOCS Position Trimmed by Sierra Summit Advisors LLC - MarketBeat
Nomura Asset Management Co. Ltd. Acquires Shares of 7,202 Doximity, Inc. $DOCS - MarketBeat
Nemes Rush Group LLC Invests $1.11 Million in Doximity, Inc. $DOCS - MarketBeat
Franklin Resources Inc. Acquires 1,108,162 Shares of Doximity, Inc. $DOCS - MarketBeat
Prudential PLC Makes New Investment in Doximity, Inc. $DOCS - MarketBeat
Robust Financial Progress and Strategic Adjustments - StocksToTrade
Doximity Stock Surges Amid Strong Earnings and Strategic Outlook - StocksToTrade
Doximity (DOCS) Shines with Strong Q2 Results, Revenue Projections - timothysykes.com
Neo Ivy Capital Management Makes New Investment in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. $DOCS Shares Bought by Handelsbanken Fonder AB - MarketBeat
Ensign Peak Advisors Inc Has $42.67 Million Position in Doximity, Inc. $DOCS - MarketBeat
Should Raymond James’ AI-Focused Upgrade Require Action From Doximity (DOCS) Investors? - Yahoo Finance
Doximity Projects Strong Q3 Revenue Guidance Amid Healthcare Shifts - StocksToTrade
Doximity Surges with Strong Q2 Results and Strategic Roadmap - StocksToTrade
Is Doximity’s Recent 24% Pullback a Chance or a Caution for Investors in 2025? - Yahoo Finance
Doximity Stock Climbs: Strong Financial Performance and Analyst Upgrades - timothysykes.com
Doximity’s Revenue Surge and Upbeat Forecasts Propel Stock Forward - timothysykes.com
Why Is Doximity (DOCS) Stock Soaring Today - The Globe and Mail
Doximity’s Unexpected Surge: Analyzing the Latest Performance - StocksToTrade
Doximity rises after Raymond James upgrades to 'strong buy' - TradingView
Doximity upgraded at Raymond James on improving long-term growth visibility - MSN
Raymond James bullish on Doximity saying long term growth trumps seasonal noise - Investing.com Canada
Hims & Hers Accelerates Its Clinician-Led, Platform-Driven Care Model - sharewise.com
EFG Asset Management Americas Corp. Acquires Shares of 26,601 Doximity, Inc. $DOCS - MarketBeat
Raymond James upgrades Doximity stock rating to Strong Buy on compelling valuation - Investing.com
Doximity, Inc. $DOCS Shares Sold by Empowered Funds LLC - MarketBeat
Doximity, SentinelOne, Asure Software, Workday, and Bandwidth Shares Are Falling, What You Need To Know - Finviz
Doximity: Strong Growth but What's Next? - AOL.com
Is Doximity Inc. stock a top pick in earnings seasonJuly 2025 Closing Moves & Weekly High Return Forecasts - newser.com
Can Doximity’s (DOCS) Share Buybacks and Earnings Strength Tell Us More About Its Growth Vision? - simplywall.st
Will Doximity Inc. Class stock outperform benchmarks2025 Market Overview & Expert Curated Trade Ideas - newser.com
Will Doximity Inc. Class stock maintain strong growthQuarterly Performance Summary & Weekly Breakout Stock Alerts - newser.com
How risky is Doximity Inc. Class stock compared to peersJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - newser.com
Will Doximity Inc. Class stock benefit from mergers2025 Price Targets & Weekly High Return Stock Opportunities - newser.com
Why Doximity Inc. Class stock could outperform next yearEarnings Performance Report & Free AI Powered Buy and Sell Recommendations - newser.com
Real time social sentiment graph for Doximity Inc.Market Volume Report & Verified Trade Idea Suggestions - newser.com
Is Doximity Inc. stock overvalued by current metricsTrade Exit Summary & Entry Point Confirmation Alerts - newser.com
Will Doximity Inc. stock recover faster than market2025 Short Interest & Stepwise Trade Signal Guides - newser.com
Stocks to Buy & Sell: Volatility Analysis for Doximity, Marriott, International PaperNews and Statistics - IndexBox
Doximity (NASDAQ:DOCS) Sets New 52-Week LowWhat's Next? - MarketBeat
Chmn Tangney Surrenders 8,005 Of Doximity Inc [DOCS] - TradingView
Doximity Inc (DOCS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.49%
1.35%
자본화:
|
볼륨(24시간):